Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

1.3%

8 terminated/withdrawn out of 622 trials

Success Rate

94.1%

+7.5% vs industry average

Late-Stage Pipeline

16%

98 trials in Phase 3/4

Results Transparency

3%

4 of 127 completed trials have results

Key Signals

159 recruiting4 with results

Enrollment Performance

Analytics

N/A
184(45.9%)
Phase 2
73(18.2%)
Phase 4
60(15.0%)
Phase 3
38(9.5%)
Phase 1
27(6.7%)
Early Phase 1
19(4.7%)
401Total
N/A(184)
Phase 2(73)
Phase 4(60)
Phase 3(38)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (622)

Showing 20 of 622 trials
NCT07697053Completed

Predictors of Epidural Depth in Percutaneous Nephrolithotomy and Model Development

Role: lead

NCT07841249Recruiting

Cardiorespiratory Fitness After Lobectomy Versus Sublobar Resection

Role: lead

NCT07838415Recruiting

Multimodalomics-based Construction of Spatiotemporal Characteristics of Dynamic Liver Cancer Microenvironment to Characterize the Clinical Application of Immune Mechanisms in Liver Cancer

Role: lead

NCT07837739Recruiting

Adjuvant EGFR-TKI Therapy After Surgery for EGFR-Mutant High-Risk Stage IA2-IIB NSCLC

Role: lead

NCT07803705Not ApplicableNot Yet Recruiting

Efficacy of Mazdutide on Fatty Pancreas

Role: lead

NCT07827456Not ApplicableNot Yet Recruiting

MRI-Guided Temporal Interference Stimulation for Parkinson's Disease

Role: lead

NCT06620809Phase 1Recruiting

The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum Disorders

Role: lead

NCT06954116Phase 2Recruiting

Iparomlimab and Tuvonralimab as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With High Risk of Recurrence

Role: lead

NCT07788157Not ApplicableRecruiting

Effects of Fospropofol Disodium TIVA and IVIH on Surgical Field Quality in Adult ESS

Role: lead

NCT07339540Early Phase 1Active Not Recruiting

the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune Diseases

Role: lead

NCT07822152Phase 1Recruiting

Human Umbilical Cord Mesenchymal Stem Cell Injection for Diabetic Nephropathy

Role: lead

NCT07021209Phase 1Recruiting

GT719 Injection for Recurrent/Refractory Antibody-mediated Neurological Immune Diseases

Role: collaborator

NCT07815418Completed

The Relationship Between Novel Virological Indicators and Treatment With Different Nucleotide Analogues and the Prognosis of HBV-ACLF Patients

Role: lead

NCT07811895Not ApplicableNot Yet Recruiting

Dual GIP/GLP-1 Receptor Agonist in Obese Women Before Frozen Embryo Transfer

Role: collaborator

NCT06358209Not ApplicableRecruiting

Safety and Efficacy of Ventricular Irrigation for Ventriculitis

Role: collaborator

NCT07183878Not ApplicableRecruiting

Venetoclax-Enhanced BUCY vs. Standard BUCY Conditioning in High-Risk AML and MDS Patients Undergoing Allo-HSCT (Ven-BUCY Study)

Role: collaborator

NCT07794514Not ApplicableRecruiting

Belumosudil Versus Ruxolitinib for Steroid-Refractory or Breakthrough Hepatic cGVHD

Role: collaborator

NCT07347990Not ApplicableRecruiting

Safety and Efficacy of Iptacopan in Patients With High-Risk Transplantation-Associated Thrombotic Microangiopathy

Role: collaborator

NCT06187961Phase 2Recruiting

HAIC, Lenvatinib, and Cadonilimab as Conversion Therapy for Initially Unresectable Hepatocellular Carcinoma

Role: lead

NCT06990412Not ApplicableCompleted

A Clinical Trial to Evaluate the Safety and Efficacy of an Implantable Wireless Brain-Computer Interface（BCI）System NEO in Patients With Tetraplegia

Role: collaborator